Majem, M.; Cobo, M.; Isla, D.; Marquez-Medina, D.; Rodriguez-Abreu, D.; Casal-Rubio, J.; Moran-Bueno, T.; Bernabé-Caro, R.; Pérez-Parente, D.; Ruiz-Gracia, P.;
et al. PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis. J. Clin. Med. 2021, 10, 1365.
https://doi.org/10.3390/jcm10071365
AMA Style
Majem M, Cobo M, Isla D, Marquez-Medina D, Rodriguez-Abreu D, Casal-Rubio J, Moran-Bueno T, Bernabé-Caro R, Pérez-Parente D, Ruiz-Gracia P,
et al. PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis. Journal of Clinical Medicine. 2021; 10(7):1365.
https://doi.org/10.3390/jcm10071365
Chicago/Turabian Style
Majem, Margarita, Manuel Cobo, Dolores Isla, Diego Marquez-Medina, Delvys Rodriguez-Abreu, JoaquÃn Casal-Rubio, Teresa Moran-Bueno, Reyes Bernabé-Caro, Diego Pérez-Parente, Pedro Ruiz-Gracia,
and et al. 2021. "PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis" Journal of Clinical Medicine 10, no. 7: 1365.
https://doi.org/10.3390/jcm10071365
APA Style
Majem, M., Cobo, M., Isla, D., Marquez-Medina, D., Rodriguez-Abreu, D., Casal-Rubio, J., Moran-Bueno, T., Bernabé-Caro, R., Pérez-Parente, D., Ruiz-Gracia, P., Arroyo, M. M., & Paz-Ares, L.
(2021). PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis. Journal of Clinical Medicine, 10(7), 1365.
https://doi.org/10.3390/jcm10071365